International Journal of Molecular and Cellular Medicine

Scope & Guideline

Exploring Innovations in Cell Biology and Genetics

Introduction

Delve into the academic richness of International Journal of Molecular and Cellular Medicine with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2251-9637
PublisherCELLULAR & MOLECULAR BIOLOGY RESEARCH CENTER
Support Open AccessNo
CountryIran
TypeJournal
Convergefrom 2016 to 2024
AbbreviationINT J MOL CELL MED / Int. J. Mol. Cell. Med.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBABOL UNIV MEDICAL SCIENCES, GANJAFROUZ AVE, BABOL 4717647745, IRAN

Aims and Scopes

The International Journal of Molecular and Cellular Medicine focuses on advancing knowledge in the fields of molecular and cellular biology, particularly as they relate to medicine. The journal publishes high-quality research that contributes to the understanding of disease mechanisms and therapeutic strategies, with an emphasis on innovative methodologies.
  1. Molecular Mechanisms of Disease:
    Research exploring the molecular underpinnings of various diseases, including cancer, autoimmune disorders, and infectious diseases, with a focus on identifying potential therapeutic targets.
  2. Cellular Responses and Therapies:
    Studies on cellular behaviors, including apoptosis, proliferation, and differentiation, particularly in relation to therapeutic strategies such as stem cell therapy and drug resistance.
  3. Biomarkers and Prognostic Factors:
    Investigations into the role of biomarkers in disease prognosis and therapy response, utilizing meta-analyses and novel bioinformatics approaches.
  4. Innovative Therapeutic Approaches:
    Research on novel therapeutic agents, including natural compounds, synthetic drugs, and combination therapies, aimed at improving treatment outcomes in various diseases.
  5. In Silico and In Vitro Studies:
    Utilization of computational models alongside laboratory experiments to validate hypotheses regarding disease mechanisms and treatment efficacy.
Recent publications in the journal indicate a clear trend towards interdisciplinary research that integrates molecular biology, genetics, and therapeutic development. Emerging themes reflect current scientific interests and the evolving landscape of medical research.
  1. Role of Non-Coding RNAs in Disease:
    There is a growing focus on the implications of long non-coding RNAs (lncRNAs) and microRNAs in disease progression and therapy, highlighting their potential as biomarkers and therapeutic targets.
  2. Immunotherapy and Inflammation:
    Research into the immune response, particularly the role of immune checkpoints and inflammatory cytokines in cancer and autoimmune diseases, is increasingly prominent, reflecting the rise of immunotherapeutic strategies.
  3. Personalized Medicine and Genomics:
    Studies leveraging genomic data to tailor treatments and predict outcomes are on the rise, emphasizing the importance of personalized approaches in clinical settings.
  4. Natural Products and Phytotherapy:
    There is an uptick in research exploring the therapeutic potential of natural compounds derived from plants, showcasing their role in cancer therapy and other diseases.
  5. Neurobiology and Mental Health:
    Emerging studies are increasingly exploring the molecular basis of neurodegenerative diseases and mental health disorders, reflecting a broader commitment to understanding brain health.

Declining or Waning

As the journal continues to evolve, certain themes appear to be losing prominence in recent publications. This decline may reflect shifting research priorities or advancements in other areas of molecular and cellular medicine.
  1. Traditional Pharmacological Approaches:
    There is a noticeable decrease in studies focusing solely on classical pharmacological treatments without integrating novel therapeutic modalities or molecular insights.
  2. Single-Disease Focus:
    Research that targets a single disease without broader implications or connections to other conditions is becoming less common, as the field moves towards more integrative and multidisciplinary approaches.
  3. Basic Cell Culture Studies:
    While foundational, studies that rely solely on basic cell culture without in vivo validation or clinical relevance are seeing reduced publication rates, as the field emphasizes translational research.

Similar Journals

DNA AND CELL BIOLOGY

Illuminating the Path of Cellular Advancements
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

FEBS Journal

Exploring New Horizons in Molecular Biology
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

FASEB JOURNAL

Illuminating the Pathways of Health and Disease
Publisher: WILEYISSN: 0892-6638Frequency: 12 issues/year

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

CELL PROLIFERATION

Empowering Global Collaboration in Cell Biology
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

BMC Molecular and Cell Biology

Empowering open access to vital biological research.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Exploring the Intersection of Cell Biology and Medicine
Publisher: WILEYISSN: 1582-1838Frequency: 12 issues/year

Journal of Cellular and Molecular Medicine, published by Wiley, stands at the forefront of research excellence in the fields of cell biology and molecular medicine. With an impressive impact factor reflected in its 2023 Q2 category ranking for both Cell Biology and Molecular Medicine, this journal provides a vital platform for researchers and professionals alike, fostering innovative findings and groundbreaking discoveries since its inception in 2000. Maintaining an open access policy since 2012, the journal ensures that knowledge is freely disseminated, promoting collaboration and progress across the scientific community. With robust rankings in the Scopus database, including a position within the top 85th percentile in Molecular Medicine, the journal remains committed to advancing understanding of cellular functions and their implications in health and disease. Researchers, professionals, and students will find a treasure of high-quality articles and reviews that not only catalyze academic dialogue but also contribute significantly to practical applications in the life sciences.

Molecular Biology Research Communications

Driving impactful research in biochemistry and molecular biology.
Publisher: SHIRAZ UNIVISSN: 2322-181XFrequency: 4 issues/year

Molecular Biology Research Communications is a distinguished academic journal published by Shiraz University, focusing on the critical and rapidly evolving fields of biochemistry and molecular biology. With an ISSN of 2322-181X and an E-ISSN of 2345-2005, this journal serves as an essential platform for researchers, professionals, and students to disseminate significant findings that contribute to the advancement of knowledge in these disciplines. The journal, operating from Shiraz, Iran, is notable for its contributions from both local and international scholars, offering invaluable insights and fostering scientific collaboration. Although currently indexed in the Q4 quartile across its categories, the journal aims to enhance its impact and visibility in the field as it converges years of research from 2017 to 2024. While the open access option is not available, the journal's commitment to high-quality peer-reviewed research provides a respected avenue for publication.

MOLECULAR MEDICINE

Bridging Research and Practice in Molecular Medicine
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

Cells

Advancing the Frontiers of Cellular Research
Publisher: MDPIISSN: Frequency: 24 issues/year

Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.

MOLECULAR AND CELLULAR BIOLOGY

Exploring the Depths of Molecular Complexity
Publisher: TAYLOR & FRANCIS INCISSN: 0270-7306Frequency: 24 issues/year

MOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.